Oxfendazole
Oxfendazole is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets
Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
Clinical Trials (8)
One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets
Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers
Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults
Single Ascending Dose Safety Study of Oxfendazole
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8